Table 1 Characteristics of AIB Phase II study group

Age (years)

52.5 +- 9.2

47.4 +- 10.0

Weight (KG)

85.7 +- 16.1

66.3 +- 13.7

Height (cm)

177.5 +- 12.6

163.1 +- 11.3

Hypertensive

3.1%

1.2%

Daytime systolic BP (mmHg)

128.2 +- 10.3

118.3 +- 9.9

Daytime diastolic BP (mmHg)

80.8 +- 7.7

75.6 +- 7.3

Nighttime systolic BP (mmHg)

108.7 +- 9.8

101.5 +- 8.6

Nighttime diastolic BP (mmHg)

62.5 +- 7.5

58.1 +- 6.3

Total cholesterol (mmol/L)

5.7 +- 1.2

5.3 +- 1.2

Triglycerides (mmol/L)

1.5 +- 0.9

1.0 +- 0.6

Diabetes mellitus (%)

0.8%

0.6%

Smokers (Current/Ex) (%)

32.4%

27.9%

Medication:

Antihypertensive (%)

3.6%

3.7%

Hormone replacement therapy

0%

21%

Anti-arrhythmic

0.5%

0%